Apexigen, Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q2 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Apexigen, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q2 2023.
  • Apexigen, Inc. Debt-to-equity for the quarter ending June 30, 2023 was 361 %, a 933% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2023 361 +326 +933% Jun 30, 2023
Q1 2023 207 +187 +933% Mar 31, 2023
Q4 2022 114 +94.2 +464% Dec 31, 2022
Q3 2022 81 +80.1 +8989% Sep 30, 2022
Q2 2022 35 Jun 30, 2022
Q1 2022 20 Mar 31, 2022
Q4 2021 20.3 Dec 31, 2021
Q3 2021 0.89 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.